New AGA clinical practice guidelines highlight the role of noninvasive biomarkers, including fecal calprotectin, fecal lactoferrin and C-reactive protein, for the management of patients with ulcerative colitis.
“Despite the fact that early proactive assessment of bowel inflammation is associated with superior long-term outcomes, there is significant variability in utilization,” Siddharth Singh, MD, assistant professor of medicine at the University of California, San Diego, and colleagues wrote in Gastroenterology. “Moreover, in routine clinical practice, repeated endoscopic